Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Eur Rev Med Pharmacol Sci ; 27(24): 12088-12102, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38164871

ABSTRACT

OBJECTIVE: Janus Kinase (JAK) inhibitors have been extensively evaluated for their potential in the management of various diseases. Despite previous research on this topic, there is a lack of bibliometric analysis that summarizes research trends on JAK inhibitors. This study aims to provide a comprehensive overview of the top 100 most frequently cited studies on JAK inhibitors over the last ten years. MATERIALS AND METHODS: The Web of Science database was used to screen and extract relevant studies on JAK inhibitors. The top 100 studies most cited within the JAK inhibitor-related research were identified and evaluated, and various data such as the year of publication, study focus and keywords, author information, and number of citations were extracted and analyzed for further examination. RESULTS: In the top 100 most cited studies of JAK inhibitors, more than 70% of studies focused on the role of JAK inhibitors in disease treatments, with 42% of these studies focused on using JAK inhibitors as treatment for autoimmune diseases and 19 of them focused on the treatment of neoplasms. Time trend analysis revealed that the keywords "tofacitinib", "atopic dermatitis", and "rheumatoid arthritis" were widely mentioned in 2016, while new trends emerged in 2018, with "ruxolitinib" and "baricitinib" being more commonly mentioned. CONCLUSIONS: The top 100 most frequently cited studies on JAK inhibitors focused primarily on the safety and efficacy of these inhibitors in the management of various diseases, particularly inflammatory diseases and neoplasms. The results can serve as a valuable reference for rheumatologists and immunologists interested in the development of JAK inhibitors and expanding future research fields.


Subject(s)
Arthritis, Rheumatoid , Autoimmune Diseases , Janus Kinase Inhibitors , Neoplasms , Humans , Janus Kinase Inhibitors/therapeutic use , Janus Kinase Inhibitors/pharmacology , Bibliometrics
3.
J Eur Acad Dermatol Venereol ; 27(4): 468-72, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22339888

ABSTRACT

BACKGROUND: Alopecia areata (AA) is regarded to be mediated by autoimmune process, and manifests as patchy non-scarring hair loss with occult onset. Little is known about AA occurring later in life. OBJECTIVE: To define the characteristics of late-onset AA. METHODS: Patients with first onset of AA at age 50 years and above were retrospectively recruited from two separate institutes in southern and northern Taiwan. The onset age, patterns, severity, past history, serological findings and therapeutic responses were reviewed. RESULTS: Seventy-three AA patients were enrolled, including 49 females (67%) and 24 males (33%). The onset age ranged from 50-78 years with the median age of 57 years. Multifocal lesions (41%) constituted the most common pattern and 55% of the recruited patients had a hair loss of less than 10%. Seventeen patients (23%) had co-existent dermatological or systemic diseases while six patients (8%) had a history of malignancy. Among 27 patients (37%) with available laboratory data, positive anti-nuclear antibody, anti-microsomal antibody and anti-thyroglobulin antibody was demonstrated in 26%, 40% and 30% of them, respectively. Association with personal or family history of atopy was absent. In 15 patients of follow-up longer than 6 months, a complete hair regrowth was found in three patients with mild disease severity. CONCLUSION: Late-onset AA is characterized by marked female predominance and milder disease activity with increasing age. The link to cancer in the old age remains to be determined. The influence of aging on the pathogenesis and prognosis of AA deserves further studies.


Subject(s)
Alopecia Areata/physiopathology , Age of Onset , Aged , Alopecia Areata/complications , Alopecia Areata/epidemiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Taiwan/epidemiology
4.
J Eur Acad Dermatol Venereol ; 27(8): 1026-34, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23176122

ABSTRACT

BACKGROUND: Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furthermore, in comparison with Caucasian patients, Asian patients with AGA have different types of hair loss and family histories which may alter the treatment response. There is currently no published AGA guideline for Asian patients. OBJECTIVES: The Asian Consensus Committee for Androgenetic Alopecia aimed to develop an algorithmic guideline, based on the basic and specific (BASP) classification, for the treatment of AGA especially in Asian patients. METHODS: The committee collaborated extensively on reviewing available literature on AGA treatment in order to formulate an algorithmic guideline on AGA management. RESULTS: Previously published guidelines based on pre-existing classifications of AGA cannot easily classify the patterns of AGA that are more frequently seen in Asians. The BASP classification not only facilitates the development of a unified and simplified algorithm, but also overcomes the disadvantages of previously reported classification systems. CONCLUSIONS: The proposed treatment guideline for AGA based on the BASP classification may be useful for dermatologists in their approach to treating Asian patients with AGA in clinical practice. Ideally, clinicians should try to utilize this guideline consistently in their practice to monitor treatment response with the goal of enhancing successful outcomes. This will help boost patients' confidence and self-esteem, thus improving patient' compliance with the prescribed treatments.


Subject(s)
Alopecia/drug therapy , Adult , Algorithms , Humans , Male , Middle Aged
5.
Oncogene ; 30(14): 1716-26, 2011 Apr 07.
Article in English | MEDLINE | ID: mdl-21132010

ABSTRACT

Guanine nucleotide binding protein-like 3-like (GNL3L) is a nucleolar protein and the vertebrate paralogue of nucleostemin (NS). We previously reported that nucleoplasmic mobilization of NS stabilizes MDM2 (mouse double minute 2). Here, we investigated the role of GNL3L as a novel MDM2 regulator. We found that GNL3L binds MDM2 in vivo and displays the same function as NS in stabilizing MDM2 protein and preventing its ubiquitylation. The interaction between GNL3L and MDM2 also takes place in the nucleoplasm. However, the MDM2 regulatory activity of GNL3L occurs constitutively and does not so much depend on the nucleolar release mechanism as NS does. GNL3L depletion triggers G2/M arrest in the p53-wild-type HCT116 cells more than in the p53-null cells, and upregulates specific p53 targets (that is, Bax, 14-3-3σ and p21) without affecting the ubiquitylation or stability of p53 proteins. The inhibitory activity of GNL3L on p53-mediated transcription correlates with the increased expression of GNL3L and reduced expression of 14-3-3σ and p21 in human gastrointestinal tumors. This work shows that in contrast to most nucleolar proteins that negatively control MDM2, GNL3L and NS are the only two that are designed to stabilize MDM2 protein under basal or induced condition, respectively, and may act as tumor-promoting genes.


Subject(s)
Cell Cycle/drug effects , GTP-Binding Proteins/metabolism , Nuclear Proteins/metabolism , Proto-Oncogene Proteins c-mdm2/metabolism , Tumor Suppressor Protein p53/metabolism , 14-3-3 Proteins/biosynthesis , Biomarkers, Tumor/biosynthesis , Carcinoma/metabolism , Cell Division , Cyclin-Dependent Kinase Inhibitor p21/biosynthesis , Exonucleases/biosynthesis , Exoribonucleases , G2 Phase , GTP-Binding Proteins/genetics , Gastrointestinal Neoplasms/metabolism , HCT116 Cells , Humans , Nuclear Proteins/genetics , Ubiquitination/drug effects , Up-Regulation , bcl-2-Associated X Protein/biosynthesis
6.
Neuroscience ; 164(2): 435-43, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19682558

ABSTRACT

Pertussis toxin (PTX) treatment results in ADP-ribosylation of Gi-protein and thus in disruption of mu-opioid receptor signal transduction and loss of the antinociceptive effect of morphine. We have previously demonstrated that pretreatment with ultra-low dose naloxone preserves the antinociceptive effect of morphine in PTX-treated rats. The present study further examined the effect of ultra-low dose naloxone on mu-opioid receptor signaling in PTX-treated rats and the underlying mechanism. Male Wistar rats implanted with an intrathecal catheter received an intrathecal injection of saline or PTX (1 microg in 5 microl of saline), then, 4 days later, were pretreated by intrathecal injection with either saline or ultra-low dose naloxone (15 ng in 5 microl of saline), followed, 30 min later, by saline or morphine (10 microg in 5 microl of saline). Four days after PTX injection, thermal hyperalgesia was observed, together with increased coupling of excitatory Gs-protein to mu-opioid receptors in the spinal cord. Ultra-low dose naloxone pretreatment preserved the antinociceptive effect of morphine, and this effect was completely blocked by the mu-opioid receptor antagonist CTOP, but not by the kappa-opioid receptor antagonist nor-BNI or the delta-opioid receptor antagonist naltrindole. Moreover, a co-immunoprecipitation study showed that ultra-low dose naloxone restored mu-opioid receptor/Gi-protein coupling and inhibited the PTX-induced mu-opioid receptor/Gs-protein coupling. In addition to the anti-neuroinflammatory effect and glutamate transporter modulation previously observed in PTX-treated rats, the re-establishment of mu-opioid receptor Gi/Go-protein coupling is involved in the restoration of the antinociceptive effect of morphine by ultra-low dose naloxone pretreatment by normalizing the balance between the excitatory and inhibitory signaling pathways. These results show that ultra-low dose naloxone preserves the antinociceptive effect of morphine, suppresses spinal neuroinflammation, and reduces PTX-elevated excitatory Gs-coupled opioid receptors in PTX-treated rats. We suggest that ultra-low dose naloxone might be clinically valuable in pain management.


Subject(s)
Analgesics, Opioid/pharmacology , Morphine/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Pain/drug therapy , Pain/metabolism , Analgesics, Opioid/administration & dosage , Animals , Drug Therapy, Combination , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , GTP-Binding Protein alpha Subunits, Gs/metabolism , Male , Morphine/administration & dosage , Naloxone/administration & dosage , Narcotic Antagonists/administration & dosage , Pain/chemically induced , Pertussis Toxin , Rats , Rats, Wistar , Receptors, Opioid, mu/antagonists & inhibitors , Receptors, Opioid, mu/metabolism , Spinal Cord/drug effects , Spinal Cord/metabolism
7.
Neuroscience ; 159(4): 1244-56, 2009 Apr 10.
Article in English | MEDLINE | ID: mdl-19409222

ABSTRACT

We previously demonstrated that ultra-low dose naloxone restores the antinociceptive effect of morphine in rats with pertussis toxin (PTX)-induced thermal hyperalgesia by reversing the downregulation of glutamate transporter (GT) expression and suppressing spinal neuroinflammation. In the present study, we examined the underlying mechanisms of this anti-inflammatory effect in PTX-treated rats, particularly on the expression of GTs. Male Wistar rats were implanted with an intrathecal catheter and, in some cases, with a microdialysis probe. All rats were injected intrathecally with saline (5 microl) or PTX (1 microg), then, 4 days later, were randomly assigned to receive a single injection of saline, ultra-low dose naloxone (15 ng), or the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 (5 microg), followed by morphine injection (10 microg) 30 min later. Our results showed that PTX injection induced activation of microglia and a significant increase in P-p38 MAPK expression in the spinal cord. Ultra-low dose naloxone plus morphine significantly inhibited the effect of PTX on P-p38 MAPK expression in the spinal cord, while the p38 MAPK inhibitor SB203580 attenuated the PTX-induced mechanical allodynia, thermal hyperalgesia, increase in spinal cerebrospinal fluid excitatory amino acids, and downregulation of GTs. These results show that the restoration of the antinociceptive effect of morphine and GT expression in PTX-treated rats by ultra-low dose naloxone involves suppression of the p38 MAPK signal transduction cascade.


Subject(s)
Hyperalgesia/drug therapy , Morphine/administration & dosage , Naloxone/administration & dosage , Narcotic Antagonists/administration & dosage , Narcotics/administration & dosage , p38 Mitogen-Activated Protein Kinases/metabolism , Amino Acid Transport System X-AG/metabolism , Animals , Enzyme Inhibitors/administration & dosage , Excitatory Amino Acids/cerebrospinal fluid , Hyperalgesia/chemically induced , Imidazoles/administration & dosage , MAP Kinase Signaling System/drug effects , Male , Microglia/drug effects , Pertussis Toxin , Pyridines/administration & dosage , Random Allocation , Rats , Rats, Wistar , Spinal Cord/drug effects , Spinal Cord/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
8.
Nutr Metab Cardiovasc Dis ; 19(4): 241-6, 2009 May.
Article in English | MEDLINE | ID: mdl-18815016

ABSTRACT

BACKGROUND AND AIMS: This study aimed to elucidate the relationship between brachial-ankle pulse wave velocity (baPWV) and conventional cardiovascular risk factors. METHODS AND RESULTS: A total of 192 subjects with low to intermediate risk was enrolled in a cardiovascular evaluation program. A multiple regression model was built to find significant cardiovascular biomarkers for predicting baPWV. A logistic regression model was developed to associate baPWV and other biomarkers with the risk of cardiac diastolic dysfunction. A total of 123 men (mean age: 52.6+/-12.0) and 69 women (mean age: 51.7+/-10.4) was included. Age, blood pressure, C-reactive protein, serum homocysteine, heart rate, and blood urea nitrogen were positively predictive of increased pulse wave velocity. In turn, baPWV increased the risk (odds ratio: 1.257 for each m/s, 95% CI: 1.105 approximately 1.430, p<0.001) and high-density lipoprotein decreased the risk for cardiac diastolic dysfunction (0.962 for each mg/dl, 95% CI: 0.925 approximately 1.000, p=0.05). The correlation between baPWV and Framingham 10-year risk was moderate (men: r=0.306, p=0.002; women r=0.548, p<0.001). CONCLUSION: The results suggest that baPWV is a composite risk factor for early atherosclerotic change and a predictor for the development of diastolic dysfunction and long-term cardiovascular risk.


Subject(s)
Ankle/blood supply , Atherosclerosis/physiopathology , Blood Pressure , Brachial Artery/physiopathology , Cardiovascular Diseases/etiology , Pulsatile Flow , Adult , Age Factors , Aged , Atherosclerosis/complications , Biomarkers/blood , Blood Urea Nitrogen , C-Reactive Protein , Cardiovascular Diseases/physiopathology , Elasticity , Female , Heart Rate , Homocysteine/blood , Humans , Lipoproteins, HDL/blood , Logistic Models , Male , Middle Aged , Odds Ratio , Retrospective Studies , Risk Assessment , Risk Factors , Taiwan
9.
Br J Dermatol ; 159(3): 697-703, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18616780

ABSTRACT

BACKGROUND: Melasma is an acquired, chronic hypermelanosis for which therapy remains a challenge. OBJECTIVES: To compare the efficacy and safety of a triple combination [TC: fluocinolone acetonide 0.01%, hydroquinone (HQ) 4%, tretinoin 0.05%] vs. HQ 4% after 8 weeks of treatment of moderate to severe facial melasma in Asian patients. METHODS: This was a multicentre, randomized, controlled, investigator-blinded, parallel comparison study. East and South-East Asian patients aged 18 years or older, with a clinical diagnosis of moderate to severe melasma, were enrolled in this study. Patients were enrolled at baseline and treated daily for 8 weeks with TC cream (one application at bedtime) or HQ cream (twice daily). There were four study visits: at baseline and weeks 2, 4 and 8. The primary efficacy variable was the melasma global severity score (GSS). Other outcome measures included Melasma Area and Severity Index, global improvement and patient satisfaction. Safety was assessed through the reporting of adverse events. RESULTS: TC had superior efficacy to HQ for the primary variable: 77/120 patients (64.2%) on TC had GSS 'none' or 'mild' at week 8 vs. 48/122 patients (39.4%) on HQ (P < 0.001). The secondary efficacy variables confirmed these results. Patient satisfaction was in favour of TC (90/127, 70.8%, vs. 64/129, 49.6%; P = 0.005). More patients had related adverse events on TC (63/129, 48.8%) than on HQ (18/131, 13.7%) but most were mild and none was severe. CONCLUSIONS: Efficacy in Asians and patient satisfaction were superior with the fixed TC than with HQ 4%.


Subject(s)
Facial Dermatoses/drug therapy , Fluocinolone Acetonide/administration & dosage , Hydroquinones/administration & dosage , Melanosis/drug therapy , Tretinoin/administration & dosage , Administration, Cutaneous , Adult , Analysis of Variance , Asian People , Double-Blind Method , Drug Combinations , Female , Humans , Male , Melanosis/ethnology , Melanosis/psychology , Middle Aged , Ointments , Patient Satisfaction , Treatment Outcome
10.
Neuroscience ; 153(3): 823-31, 2008 May 15.
Article in English | MEDLINE | ID: mdl-18400403

ABSTRACT

We previously showed that intrathecal co-administration of amitriptyline with morphine upregulates the expression of the glial glutamate transporters glutamate-aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1) and restores neuronal glutamate transporter excitatory amino acid carrier 1 (EAAC1) expression in chronically morphine-infused rats. The present study examined the role of nuclear transcription factor-kappaB (NF-kappaB) in the regulation of the expression of GLAST, GLT-1, and EAAC1 following long-term amitriptyline/morphine co-infusion. Male Wistar rats were implanted with two intrathecal catheters with or without a microdialysis probe; one of the catheters was used for continuous infusion of saline (control), morphine (15 microg/h), or morphine plus amitriptyline (both 15 microg/h) for 5 days, while the other was used for a single daily intrathecal injection of the NF-kappaB inhibitor Ro106-9920 (10 microl of 10 microM) for 5 days. We found that amitriptyline co-infusion restored the antinociceptive effect of morphine (4.5-fold right-shift in the morphine dose-response curve compared with a 65-fold right-shift in its absence) and this effect was inhibited by Ro106-9920 administration (48-fold right-shift). Moreover, amitriptyline/morphine co-infusion increased IkappaBalpha phosphorylation and the translocation of NF-kappaB p65 from the cytosol to the nucleus. Daily intrathecal injection of Ro106-9920 prevented the amitriptyline/morphine-induced NF-kappaB p65 translocation and reversed the amitriptyline/morphine-induced GLAST and GLT-1 upregulation and inhibited the restoration of EAAC1 expression. The Ro106-9920 injections abolished the inhibitory effect of amitriptyline on the morphine-evoked release of excitatory amino acids into the spinal cerebrospinal fluid (CSF) dialysates. In conclusion, amitriptyline/morphine co-infusion restores the antinociceptive effect of morphine and upregulates GLAST and GLT-1 expression and restores EAAC1 expression to baseline levels, thus reducing excitatory amino acid levels in the spinal CSF dialysates. The mechanism involves activation of the NF-kappaB pathway, but may also involve other pathways.


Subject(s)
Adrenergic Uptake Inhibitors/administration & dosage , Amino Acid Transport System X-AG/drug effects , Amitriptyline/administration & dosage , NF-kappa B/drug effects , Narcotics/pharmacology , Amino Acid Transport System X-AG/metabolism , Animals , Blotting, Western , Dose-Response Relationship, Drug , Drug Interactions , Drug Tolerance/physiology , Excitatory Amino Acids/metabolism , Fluorescent Antibody Technique , Gene Expression Regulation/drug effects , Image Processing, Computer-Assisted , Injections, Spinal , Male , Microdialysis , Morphine/pharmacology , NF-kappa B/metabolism , Pain Threshold/drug effects , Rats , Rats, Wistar , Sulfoxides/pharmacology , Tetrazoles/pharmacology , Up-Regulation
11.
Dermatol Surg ; 27(5): 446-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11359491

ABSTRACT

BACKGROUND: Tumescent liposuction is a safe procedure for removal of subcutaneous fat tissue. Because apocrine glands are located deep in the fat, surgical removal of these glands by nontumescent liposuction has been utilized for treating osmidrosis. OBJECTIVE: To evaluate the effect of tumescent liposuction in the treatment of osmidrosis and to compare the efficacy of simple tumescent liposuction and combined tumescent liposuction and curettage. METHODS: A total of 20 patients with osmidrosis (all female, age 16-44 years) were included in this study. Ten patients were treated by simple tumescent liposuction, the other 10 patients were treated by tumescent liposuction combined with curettage. The aspirates were sent for pathologic examination. At a follow-up visit, the improvement of symptoms was graded by the patient as satisfied when the odor decreased> 75%, partially satisfied when it decreased >/=50% to

Subject(s)
Axilla/surgery , Hyperhidrosis/surgery , Lipectomy/methods , Adolescent , Adult , Apocrine Glands/surgery , Curettage , Female , Humans , Odorants , Treatment Outcome
12.
Appl Opt ; 40(10): 1593-8, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-18357152

ABSTRACT

Thermal stabilities of three-cavity narrow-bandpass (NB) filters with high-index half-wave spacers and 78-102 layers of Ta(2)O(5) and SiO(2) prepared by reactive ion-assisted bipolar direct-current (dc) magnetron sputtering of tantalum and silicon targets, respectively, were investigated. Pure argon and pure oxygen were used as the sputtering gas and the reactant, respectively. The oxygen gas was introduced and ionized through the ion gun and toward the unheated BK7 glass substrate. The refractive indices of single-layer Ta(2)O(5) and SiO(2) films were 2.1 and 1.45, respectively, at 1550 nm, which were comparable with those of films prepared by other ion-assisted coating techniques. The moisture-resistant properties of the films were excellent as evidenced from the water-immersion test, implying that the packing density of the films was close to that of their bulk materials. The temperature-dependant wavelength shifts of the NB filters were <3 x 10(-3) nm/ degrees C at temperatures of <75 degrees C, indicating that the temperature-induced wavelength shift of the filter was <0.15 nm when the temperatures were raised from room temperature to 75 degrees C, which was compliant with Bellcore GR-1209-CORE generic requirements of NB filters used for optical-fiber communication systems.

13.
J Hypertens ; 18(5): 601-13, 2000 May.
Article in English | MEDLINE | ID: mdl-10826564

ABSTRACT

OBJECTIVE: To evaluate the role of nitric oxide (NO) in the development and unclipping-induced reversal of blood pressure and bilateral renal function in two-kidney, one clip (2K1C) Goldblatt hypertensive rats. METHODS: Goldblatt hypertensive rats were prepared by clipping the left renal artery 4 weeks before unclipping experiments. NG-nitro-L-arginine methyl ester (L-NAME) was administered after clipping and during unclipping to inhibit nitric oxide (NO) synthesis. Blood pressure and bilateral renal responses were measured. RESULTS: Chronic L-NAME treatment accelerated and aggravated blood pressure elevations and increased plasma nitrite and nitrate levels in 2K1C rats. Surgical removal of the renal artery clip induced profound reductions in blood pressure in rats with and without L-NAME treatment. However, the magnitude of the unclipping-induced depressor response at the first post-unclipping hour was significantly smaller in L-NAME-treated rats compared to those without L-NAME administration (15 +/- 1 versus 22 +/- 1%, P < 0.05). Two hours after unclipping, blood pressure of both groups fell to a comparable, normal level. Acute intravenous infusion of L-NAME in established 2K1C hypertensive rats further increased blood pressure. Subsequent unclipping caused a depressor response similar to that observed in hypertensive rats treated chronically with L-NAME. Despite the marked decreases in blood pressure, unclipping induced striking increases in glomerular filtration rate (GFR), urine flow and sodium and potassium excretion rates in the ipsilateral kidney. However, the magnitudes of increases in GFR and the diuretic and natriuretic responses in rats without L-NAME treatment were significantly greater than in rats with L-NAME administration. In contrast, unclipping reduced these function indices in the contralateral kidney to a similar level in rats with and without L-NAME treatment. CONCLUSIONS: NO exerts vasodilator action and thereby lessens renal artery clipping-induced blood pressure elevation. Furthermore, unclipping-induced release of NO partially contributes to the early reduction in blood pressure and changes in bilateral renal function but does not directly mediate the normalization of blood pressure after unclipping in this hypertension model.


Subject(s)
Hypertension, Renovascular/etiology , Hypertension, Renovascular/physiopathology , Nitric Oxide/physiology , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Diuresis/drug effects , Enzyme Inhibitors/pharmacology , Glomerular Filtration Rate/drug effects , Hypertension, Renovascular/therapy , Male , NG-Nitroarginine Methyl Ester/pharmacology , Natriuresis/drug effects , Nitrates/blood , Nitric Oxide Synthase/antagonists & inhibitors , Nitrites/blood , Rats , Rats, Sprague-Dawley
14.
J Neurosci ; 20(10): 3725-35, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10804214

ABSTRACT

Cell fate is determined by intrinsic programs and external cues, such as soluble signals and cell-cell contact. Previous studies have demonstrated the roles of soluble factors in the proliferation and differentiation of cortical stem cells and cell-cell contact in maintaining stem cells in a proliferative state. In the present study, we focused on the effect of cell-cell interaction on cell-fate determination. We found that density could exert a strong influence on the cell-type composition when cortical stem cells differentiate. Multipotent stem cells, which normally gave rise to neurons, astrocytes, and oligodendrocytes under high-density culture condition, differentiated almost exclusively into smooth muscle at low density. Clonal analysis indicated that smooth muscle and astrocytes were derived from a common precursor and that the density effect on cell types used an instructive mechanism on the choice of fate rather than an effect of selective survival and/or proliferation. This instructive mechanism depended on the local and not the average density of the cells. This local signal could be mimicked by membrane extract. These findings demonstrate the importance of membrane-bound signals in specifying lineage and provide the first evidence for a short-range regulatory mechanism in cortical stem cell differentiation.


Subject(s)
Cell Communication/physiology , Cerebral Cortex/cytology , Neurons/cytology , Stem Cells/cytology , Animals , Astrocytes/cytology , Cell Count , Cell Differentiation/physiology , Cell Lineage/physiology , Cell Membrane/physiology , Cells, Cultured , Female , Fetus/cytology , Muscle, Smooth/cytology , Oligodendroglia/cytology , Pregnancy , Rats , Rats, Sprague-Dawley
15.
Dermatol Surg ; 25(6): 489-91, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10469099

ABSTRACT

BACKGROUND: Cutaneous leiomyosarcoma is a rare soft tissue sarcoma with a predilection for the lower extremities. Leiomyosarcoma of the face is very rare. Subcutaneous leiomyosarcoma has a higher likelihood of recurrence and metastases than that of the superficial dermal type. OBJECTIVE: The dermatologic surgeon and pathologist should be familiar with the characters of subcutaneous leiomyosarcoma. METHODS: We report a case of subcutaneous leiomyosarcoma on the face with the results of histologic examination and immunohistochemical studies. RESULTS: Leiomyosarcoma of the face is exceedingly rare. The deep subcutaneous type is thought to arise from the smooth muscle of the vascular wall. The neoplasm we report here has deep tumor invasion, high malignancy grade (3B), and large tumor size. Wide excision and postoperative radiotherapy were performed. CONCLUSION: Subcutaneous leiomyosarcoma has a higher likelihood of recurrence and metastases than that of the superficial dermal type. The most effective treatment is wide excision with 3-5 cm lateral margins and a depth that includes subcutaneous tissue and fascia.


Subject(s)
Facial Neoplasms/pathology , Leiomyosarcoma/pathology , Soft Tissue Neoplasms/pathology , Humans , Male , Middle Aged
16.
Appl Opt ; 38(25): 5452-7, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-18324053

ABSTRACT

The influence of the TiO(2) concentration (

17.
Dermatol Surg ; 24(12): 1326-9, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9865197

ABSTRACT

BACKGROUND: There are high risks from general anesthesia and excessive bleeding associated with traditional liposuction using the dry or wet method. The blood loss has been estimated to be between 15% and 45%. The tumescent technique permits liposuction of more than 3,000 ml of fat totally by local anesthesia without sedation. The blood loss is reported to be less than 1% of aspirate. OBJECTIVE: To examine the blood loss during liposuction using tumescent technique in Chinese patients compared with that of Caucasians as published in the literature. METHODS: Hemoglobin values of patient's preoperative venous blood and infranatant of aspirate were measured in 45 consecutive cases of liposuction using the tumescent technique from May 1996 to June 1997. RESULTS: A total of 30 patients completed the study. The average blood loss was estimated to be 1.08% of aspirate. CONCLUSION: From this study, we found the blood loss in Chinese patients is comparable with that in Caucasians. Tumescent liposuction is a safe dermatologic cosmetic surgical procedure without the need of blood transfusion and general anesthesia.


Subject(s)
Asian People , Blood Loss, Surgical/physiopathology , Lipectomy/methods , Adult , Anesthesia, Local , Female , Humans , Middle Aged , Taiwan , Treatment Outcome , White People
18.
J Spinal Disord ; 11(5): 389-94, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9811098

ABSTRACT

In this retrospective study, we investigated 50 patients who had undergone primary lumbar microsurgical multiple laminotomy without spinal fusion for degenerative spinal stenosis. There were 31 men and 19 women with a median age of 66 years (35-85 years). Thirteen patients had grade I spondylolisthesis, most at L4-L5 levels (11 of 13). Single-level laminotomy was done in 13 patients, two levels in 30, and three levels in 7. The median follow-up period was 27 months (range, 15-48 months). A standardized self-reported questionnaire was used for clinical outcome study. The demographic data and clinical features of these patients were analyzed for the prognostic factors. The analysis showed excellent results in 18 patients, good in 16, fair in 8, and poor in 8, whereas 30 patients reported that they were very satisfied with the surgery results, 10 were somewhat satisfied, 2 were somewhat dissatisfied, and 8 were very dissatisfied. Therefore, the satisfactory rate of the surgery was higher if judged by patient satisfaction. Among the parameters analyzed, the presence of neurogenic claudication (p = 0.008), coexisting disease (p = 0.04), and the absence of motor deficit (p = 0.03) were associated with lower total scores. In addition, longer duration of symptoms (p = 0.04) was associated with less improvement of back pain score, whereas the absence of motor deficit (p = 0.004) was associated with less improvement of leg pain score. The presence of spondylolisthesis did not affect outcomes.


Subject(s)
Decompression, Surgical/methods , Laminectomy/methods , Microsurgery/methods , Spinal Cord Compression/surgery , Spinal Stenosis/surgery , Adult , Aged , Aged, 80 and over , Back Pain/etiology , Back Pain/surgery , Female , Follow-Up Studies , Humans , Lumbar Vertebrae/surgery , Male , Middle Aged , Patient Satisfaction , Prognosis , Retrospective Studies , Spinal Cord Compression/complications , Treatment Outcome
19.
Mol Cell Biol ; 18(11): 6447-56, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9774661

ABSTRACT

Roaz, a rat C2H2 zinc finger protein, plays a role in the regulation of olfactory neuronal differentiation through its interaction with the Olf-1/EBF transcription factor family. An additional role for the Roaz/Olf-1/EBF heterodimeric protein is suggested by its ability to regulate gene activation at a distinct promoter lacking Olf-1/EBF-binding sites. Using an in vitro binding-site selection assay (Selex), we demonstrate that Roaz protein binds to novel inverted perfect or imperfect repeats of GCACCC separated by 2 bp. We show that Roaz is capable of binding to a canonical consensus recognition sequence with high affinity (Kd = 3 nM). Analysis of the structural requirement for protein dimerization and DNA binding by Roaz reveals the role of specific zinc finger motifs in the Roaz protein for homodimerization and heterodimerization with the Olf-1/EBF transcription factor. The DNA-binding domain of Roaz is mapped to the N-terminal 277 amino acids, containing the first seven zinc finger motifs, which confers weak monomeric binding to a single half site and a stronger dimeric binding to the inverted repeat in a binding-site-dependent manner. Full-length protein can form dimers on both the inverted repeat and direct repeat but not on a single half site. These findings support the role of the TFIIIA-type Zn fingers in both protein-protein interaction and protein-DNA interaction and suggest distinct functions for specific motifs in proteins with a large number of zinc finger structures.


Subject(s)
DNA-Binding Proteins/chemistry , Saccharomyces cerevisiae Proteins , Transcription Factors/chemistry , Zinc Fingers/genetics , Amino Acid Sequence , Animals , Binding Sites/genetics , Cell Line , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/physiology , Dimerization , Gene Expression Regulation/genetics , Molecular Sequence Data , Oligodeoxyribonucleotides/chemistry , Protein Binding/physiology , Rats , Sequence Homology, Amino Acid , Trans-Activators/metabolism , Transcription Factor TFIIIA , Transcription Factors/genetics , Transcription Factors/physiology , Transcriptional Activation , Transfection/genetics
20.
Dermatol Surg ; 24(10): 1065-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9793515

ABSTRACT

BACKGROUND: The advent of high-energy carbon dioxide (CO2) laser-assisted hair transplantation in recent years provides a new recipient area technique for hair restoration surgery. It offers the advantages of less bleeding, time consumption, and graft compression. Specific laser parameters have been recommended in Caucasian but not Oriental patients. OBJECTIVE: To determine the effectiveness as well as appropriate parameters of laser hair transplantation in Oriental patients. METHODS: A Sharplan SilkTouch laser with the Flashscanner set to produce a 0.8-1-mm recipient site hole was employed for all subjects. Various CO2 laser parameters were used to compare the graft survival rate with traditional Nokor needle or microdilator methods for micrografting on each side of the scalp. A total of 20 patients joined the study in the past 18 months. A skin biopsy was performed to examine the tissue effect of the different laser parameters. RESULTS: Hair survival was less than that seen with conventional micrografting techniques in the first five cases, in whom CO2 laser parameters of 36-40 W and 0.2-0.7 seconds were used. After adjusting the parameters to 55 W and 0.1-0.15 seconds, the survival rate increased to between 80% and 90%. In addition, most patients thought the laser-prepared sites resulted in a more natural appearance and better hair density, when they were compared with conventionally prepared sites. CONCLUSIONS: From our study, we find that CO2 laser parameters of 55 W and 0.1-0.15 seconds seem to be the appropriate parameters for Oriental hair transplant patients. Further studies are required to establish laser parameters that will produce better hair survival.


Subject(s)
Alopecia/ethnology , Alopecia/surgery , Asian People , Hair Follicle/metabolism , Hair Follicle/transplantation , Laser Therapy/methods , Carbon Dioxide , Female , Humans , Male , Specimen Handling , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...